Señales en vivo de INIT.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 05:02):

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system...

Stats
Volumen de hoy	9 592.00
Volumen promedio	27 925.00
Capitalización de mercado	488.96M
EPS	SEK0 ( 2024-02-22 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-10
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-10.15
ATR14	SEK0.0670 (0.73%)

Initiator Pharma A/S Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Initiator Pharma A/S Finanzas

Annual	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK-23 412.00 (0.00 %)
EPS:	SEK-0.000400

FY	2023
Ingresos:	SEK0
Beneficio Bruto:	SEK-23 412.00 (0.00 %)
EPS:	SEK-0.000400

FY	2022
Ingresos:	SEK0
Beneficio Bruto:	SEK-38 425.00 (0.00 %)
EPS:	SEK-0.720

FY	2021
Ingresos:	SEK0.00
Beneficio Bruto:	SEK-21.63M (0.00 %)
EPS:	SEK-0.531

Financial Reports:

No articles found.

Initiator Pharma A/S

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. It develops IP2018, a monoamine reuptake inhibitor for the treatment of psychogenic erectile dysfunction; IPED2015 to treat patients suffering from organic erectile dysfunction; and IPTN2021 for targeting an orphan drug indication in severe neuropathic pain. The company's pre-clinical stage candidates include IPNP2015 for the treatment of chronic pain; and IPDP2015 for depression. Initiator Pharma A/S was incorporated in 2016 and is headquartered in Copenhagen, Denmark.

Actualizaciones en tiempo real para Initiator Pharma A/S [INIT.ST]

Upcoming Earnings Alert